LEXINGTON, Mass.–(BUSINESS WIRE)–Jan. 4, 2012– AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Frank E. Thomas, chief operating officer and interim CEO, will provide an update on the Company followed by a breakout session at the 30th Annual J.P. Morgan Healthcare Conference on January 11 at 3:00 p.m., Pacific Time.
A live audio webcast of the company’s presentation and the following breakout session along with the accompanying slide presentation will be accessible through the Investors section of the Company’s website at https://www.amagpharma.com. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website until February 11, 2012.
About AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia. For additional company information, please visit https://www.amagpharma.com.
Source: AMAG Pharmaceuticals, Inc.
AMAG Pharmaceuticals, Inc.
Amy Sullivan, 617-498-3303
Feinstein Kean Healthcare
Lynn Blenkhorn, 508-851-0930